Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells. - Wikidata - awgldk - TriplyDB

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

http://www.wikidata.org/entity/Q33934005

about

Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans.T0901317 inhibits cisplatin-induced apoptosis in ovarian cancer cells [corrected]Ligands of Therapeutic Utility for the Liver X Receptors.Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment.NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer Targeting liver X receptors in human health: deadlock or promising trail?Oxysterol receptors and their therapeutic applications in cancer conditions.The emerging roles of liver X receptors and their ligands in cancer.LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells

P2860

Q28118739-B4FDFD6F-64A3-47AB-8AEB-143AB22B5036 Q33892325-1FB60E30-9777-49EC-9C5C-91C0AD84C1E0 Q35464846-53CEFE7C-0D41-4D34-A8BB-1470D2AF4C2E Q36244293-E6679AC0-84FB-46FD-910F-8936E279B947 Q36545158-6652FC00-1072-4839-A56F-FBC75B11E478 Q37376541-389E1BC7-C469-4979-A523-8D8A280C879B Q37572922-F3F72A08-F221-474B-B2B4-091B85E8F5E6 Q37738095-1D379DBC-0EB7-4CEE-934A-206F0CD7EA96 Q37825904-9DC97742-493C-4696-91F7-FF02E6F17C68 Q38123210-DDC4A4DE-5D2A-4AD7-813C-275E921ACBA9 Q38703765-89EB592E-532C-4D51-8D53-F0286CDC5B61 Q38739920-843C1E49-97CE-4AD6-9224-6192D56613D7 Q41888020-7633E16A-B849-4242-B22F-A41667622C60

P2860

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

http://www.wikidata.org/entity/Q33934005

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

@ast

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

@en

type

label

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

@ast

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

@en

prefLabel

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

@ast

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

@en

P1433

Q33934005-28B126C3-2684-45A9-A04B-C3296156476C

P1476

Q33934005-E57DB7DE-57E4-4525-9F9A-B71B9905BB51

P2093

Q33934005-020504E7-C04C-4F49-97D8-0F85C8671FF3

Q33934005-1575C87F-D5F3-468F-9C62-63795F5AF443

Q33934005-229C8844-4F7C-41C7-A665-A05B79247454

Q33934005-27E473A6-47E5-4235-83BF-6B6E5CC0246D

P2860

Q33934005-03507BEC-7AE2-4E2A-8772-20A8B997BB11

Q33934005-186CB0A5-E778-4CFC-8704-F5FDB8F25D07

Q33934005-1EDAB37A-5C33-4D23-A9B1-CCB46868638A

Q33934005-296CCE8E-BC6D-4377-AEE8-74731E2B633A

Q33934005-39F218D5-60D4-4623-955E-2D7F5273B0CE

Q33934005-466A3C25-AB27-4D89-8ADE-0B19608A9595

Q33934005-47678286-30B4-4DF4-948B-E01E7DED59AF

Q33934005-47C5BA6C-E50C-4957-8E5C-CABE278217C3

Q33934005-4ED55248-EAE2-48B4-8F69-54239E4B3CC2

Q33934005-50948E28-922C-4BB1-A14F-A9458BF85987

P2888

Q33934005-4B9DA721-B098-45B3-8267-4EAA91A5413A

P304

Q33934005-0FDD92C3-EF1A-4081-99C3-7DB4941AC3B9

P31

Q33934005-D43E847A-9AB7-4D2A-93A4-48258A98EE6B

P356

Q33934005-8FFCB07F-0295-4519-B7B4-31EA13D0F94D

P478

Q33934005-F5B8A7E8-E291-447D-93E4-77C229436BF4

P577

Q33934005-6BFF6E45-A5C0-4BA5-975F-7371D903131C

P5875

Q33934005-6940341C-8074-424B-8000-7ADB0CAF0FE5

P6179

Q33934005-8E28A7C0-ED1A-4223-954A-AAF55E490984

P698

Q33934005-976F0EA0-B6FF-4F8E-AB16-5C81F5EE23C5

P932

Q33934005-DBC88F22-743D-448A-A0BE-98A6A735E799

P356

P1433

Journal of Ovarian Research

P1476

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.

@en

P2093

James J Rough

http://www.w3.org/2001/XMLSchema#string

John M Daly

http://www.w3.org/2001/XMLSchema#string

M Alexandra Monroy

http://www.w3.org/2001/XMLSchema#string

Smitha Yerrum

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway

LXR, a nuclear receptor that defines a distinct retinoid response pathway

A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily

CDK inhibitors: positive and negative regulators of G1-phase progression

Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist

Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells

Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation

Cancer statistics, 2005

Nuclear receptors and lipid physiology: opening the X-files

Effects of diallyl disulfide (DADS) on expression of apoptosis associated proteins in androgen independent human prostate cancer cells (PC-3).

P2888

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1757-2215-3-13

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44632087

http://www.w3.org/2001/XMLSchema#string

P6179

1013830291

http://www.w3.org/2001/XMLSchema#string

P698

20504359

http://www.w3.org/2001/XMLSchema#string

P932

2890636

http://www.w3.org/2001/XMLSchema#string